JP2013532130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532130A5 JP2013532130A5 JP2013510364A JP2013510364A JP2013532130A5 JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5 JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- compound
- pharmaceutically acceptable
- acceptable salt
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33499110P | 2010-05-14 | 2010-05-14 | |
| US61/334,991 | 2010-05-14 | ||
| US37074510P | 2010-08-04 | 2010-08-04 | |
| US61/370,745 | 2010-08-04 | ||
| US37586310P | 2010-08-22 | 2010-08-22 | |
| US61/375,863 | 2010-08-22 | ||
| PCT/US2011/036701 WO2011143669A2 (en) | 2010-05-14 | 2011-05-16 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015049960A Division JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532130A JP2013532130A (ja) | 2013-08-15 |
| JP2013532130A5 true JP2013532130A5 (lt) | 2014-11-06 |
| JP5715241B2 JP5715241B2 (ja) | 2015-05-07 |
Family
ID=49052897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510364A Active JP5715241B2 (ja) | 2010-05-14 | 2011-05-16 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
| JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP5715241B2 (lt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2534521T3 (es) | 2010-05-14 | 2015-04-23 | Dana-Farber Cancer Institute, Inc. | Composiciones y su uso en el tratamiento de neoplasia, enfermedades inflamatorias y otras enfermedades |
| US20130252331A1 (en) * | 2010-05-14 | 2013-09-26 | James Elliott Bradner | Compositions and methods for modulating metabolism |
| IN2014DN11269A (lt) * | 2012-06-25 | 2015-10-09 | Oncoethix Sa | |
| EP3030242A1 (en) * | 2013-08-06 | 2016-06-15 | Oncoethix GmbH | Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor |
| MX2016005980A (es) | 2013-11-08 | 2016-12-09 | Dana Farber Cancer Inst Inc | Terapia de combinación para el cáncer usando inhibidores de la proteína bromodominio y extra-terminal. |
| WO2015131113A1 (en) | 2014-02-28 | 2015-09-03 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| JP2018520124A (ja) * | 2015-06-26 | 2018-07-26 | テンシャ セラピューティクス，インコーポレイテッド | Ｎｕｔ正中線癌の治療 |
| CN108472299A (zh) | 2015-09-11 | 2018-08-31 | 达纳-法伯癌症研究所股份有限公司 | 乙酰胺噻吩并三唑并二氮杂环庚三烯及其用途 |
| BR112018004618A2 (pt) * | 2015-09-11 | 2018-09-25 | Dana-Farber Cancer Institute, Inc. | ciano tienotriazoldiazepinas e usos das mesmas |
| BR112018006689A2 (pt) * | 2015-10-02 | 2018-10-09 | Dana Farber Cancer Inst Inc | terapia de combinação de inibidores de bromodomínio e bloqueio de ponto de controle |
| AU2017219627B2 (en) * | 2016-02-15 | 2021-08-05 | The Regents Of The University Of Michigan | Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors |
| CA3041949A1 (en) * | 2016-12-16 | 2018-06-21 | F. Hoffmann-La Roche Ag | Process for the manufacture of diazepine derivatives |
| CN109503618A (zh) * | 2017-09-14 | 2019-03-22 | 成都海创药业有限公司 | 一种brd4抑制剂 |
| JP2021527136A (ja) * | 2018-06-13 | 2021-10-11 | ディブリー・アーゲー | 縮合トリアゼピン誘導体の調製及びｂｅｔ阻害剤としてのその使用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL330635A1 (en) * | 1996-06-12 | 1999-05-24 | Japan Tobacco Inc | Inhibitor of cytokin production, triazepin compound and intermediate compounds used for obtaining the last mentioned one |
| US7589167B2 (en) * | 2000-02-22 | 2009-09-15 | J. David Gladstone Institutes | ZA loops of bromodomains |
| JP2006519236A (ja) * | 2003-02-27 | 2006-08-24 | アボット・ラボラトリーズ | 複素環式キナーゼ阻害剤 |
| EP2239264A4 (en) * | 2007-12-28 | 2012-01-11 | Mitsubishi Tanabe Pharma Corp | ANTITUMOR AGENT |
| EP3050885B1 (en) * | 2009-11-05 | 2017-10-18 | GlaxoSmithKline LLC | Benzodiazepine bromodomain inhibitor |
-
2011
- 2011-05-16 JP JP2013510364A patent/JP5715241B2/ja active Active
-
2015
- 2015-03-12 JP JP2015049960A patent/JP5937247B2/ja active Active